Pharmaceuticals

Global Buminate Market 2026–2035 strengthening plasma-derived therapies

March 25, 2026March 25, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Buminate Market During 2026–2030?

The historical growth can be linked to the long-standing clinical application of albumin, an increase in surgical procedures, the expansion of critical care facilities, its demonstrated safety record, and a growing dependency on plasma-derived treatments.

The anticipated growth during the forecast period can be attributed to an uptick in instances of trauma, a surge in surgical procedures, an enlargement of intensive care unit facilities, the need for quick fluid replenishment, and enhanced capabilities for plasma fractionation. Concurrently, major trends expected in this period encompass the sustained application of albumin in critical care settings, increasing requirements in managing trauma and burns, a broader scope for therapies supporting surgical volume, a greater inclination towards proteins derived from plasma, and an increase in patients admitted to intensive care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20008&type=smp

What Drivers Are Expected To Influence The Buminate Market During The Forecast Period?

The rising occurrence of liver diseases is projected to fuel expansion in the buminate market moving forward. Liver ailments encompass a wide array of conditions that compromise liver function, such as cirrhosis, hepatitis, fatty liver disease, and liver cancer, frequently stemming from factors like infections, toxins, genetic predispositions, or consistent alcohol consumption. This surge in liver disease prevalence is largely attributable to unhealthy lifestyle and dietary patterns, with excessive alcohol intake, poor nutrition, and obesity contributing significantly to liver damage and fat accumulation. Buminate, a human albumin solution, aids in managing liver diseases by restoring and sustaining blood volume and osmotic pressure in patients suffering from conditions like cirrhosis or liver failure, thereby enhancing circulation, facilitating proper fluid balance, and mitigating the risk of complications such as edema and ascites. For example, in April 2025, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, reported 17,650 new chronic hepatitis B cases across 44 states and the District of Columbia in 2023, indicating a prevalence rate of 6.1 cases per 100,000 people. Consequently, the escalating prevalence of liver diseases is a key driver for growth within the buminate market.

Buminate Market Driver: Impact Of Rising Healthcare Expenditure On The Growth Of The Buminate Market

The upward trend in healthcare spending is anticipated to boost the buminate market’s growth in the coming period. Healthcare expenditure signifies the total monetary outlay on health services and related activities within a defined timeframe, typically measured annually. This increase in healthcare expenditure is attributed to an aging global population, the rise of chronic diseases, elevated service costs, greater demand, technological advancements, escalating drug prices, the repercussions of COVID-19, medical inflation, and disparities in income. Buminate stands to gain from healthcare expenditure because greater investment in healthcare infrastructure and services stimulates a higher demand for effective treatments such as Buminate, particularly for managing conditions like hypoalbuminemia and trauma, leading to wider market adoption, improved accessibility, and a consistent revenue stream for both manufacturers and healthcare providers. For instance, in May 2024, a report from the Office for National Statistics, a UK-based government department, indicated that between 2022 and 2023, healthcare spending in the UK grew by 5.6%, a notable increase compared to the 0.9% growth seen in 2022. The total UK healthcare expenditure reached approximately $317.63 billion (£292 billion) in 2023. Thus, the escalating healthcare expenditure is propelling the expansion of the buminate market.

How Are The Various Segments Of The Buminate Market Categorized?

The buminate market covered in this report is segmented –

1) By Indication: Hypoproteinemia, Burn Treatment, Cardiopulmonary Bypass Surgery

2) By Distribution Channel: Hospital Pharmacies, Outpatient Clinics, Specialty Pharmacies

3) By End-Use: Hospitals, Clinics, Ambulatory Care, Home Care

Which Major Firms Influence Developments In The Buminate Market?

Major companies operating in the buminate market are Grifols S.A.

Read the full buminate market report here:

https://www.thebusinessresearchcompany.com/report/buminate-global-market-report

Which Region Is Forecast To Lead The Buminate Market In Terms Of Market Size?

North America was the largest region in the buminate market in 2025. The regions covered in the buminate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Buminate Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20008&type=smp

Browse Through More Reports Similar to the Global Buminate Market 2026, By The Business Research Company

Trade Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/trade-finance-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Financial Analytics Market Report 2026

https://www.thebusinessresearchcompany.com/report/financial-analytics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795